Drug Database
Back to search

Netherlands· NL-90c098fadb14

Difterie-, Tetanus-, Poliomyelitisvaccin, suspensie voor injectie

A diphtherie-poliomyelitis-tetanus product containing difterietoxoïde, geadsorbeerd + poliomyelitis virus, trivalent, geinactiveerd + tetanustoxoïde, geadsorbeerd, geinactiveerd, registered in Netherlands by Bilthoven Biologicals B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC J07CA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDifterie-, Tetanus-, Poliomyelitisvac…ATCJ07CA01REGISTER NO.NL-90c098fadb14PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about difterietoxoïde, geadsorbeerd + poliomyelitis virus, trivalent, geinactiveerd + tetanustoxoïde, geadsorbeerd, geinactiveerdAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Diphtherie-poliomyelitis-tetanus is registered in 5 of 19 countries.

Countries holding a registration under ATC J07CA01 (diphtherie-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search diphtherie-poliomyelitis-tetanus products by name

Diphtherie-poliomyelitis-tetanus · ATC J07CA01

5 / 19 countries

  • Belgiumprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DIFTERIETOXOÏDE, GEADSORBEERD + POLIOMYELITIS VIRUS, TRIVALENT, GEINACTIVEERD + TETANUSTOXOÏDE, GEADSORBEERD, GEINACTIVEERD
Manufacturer
Bilthoven Biologicals B.V.
Country
Netherlands (NL)
ATC code
J07CA01
ATC class
Diphtherie-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    17641

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07CA01

Diphtherie-poliomyelitis-tetanus, as other registers publish it.

All diphtherie-poliomyelitis-tetanus products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6d366bbf-b807-43c6-91ad-37e5591de3bd
GET /v1/drugs/6d366bbf-b807-43c6-91ad-37e5591de3bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h17641_smpc.pdf",
  "strength": null,
  "atc_label": "Diphtheria-Poliomyelitis-Tetanus",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg17641",
  "excipients": [
    "ALUMINIUMFOSFAAT",
    "FENOXYETHANOL",
    "FORMALDEHYDE",
    "NATRIUMCHLORIDE",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "DIFTERIETOXOÏDE, GEADSORBEERD",
    "POLIOMYELITIS VIRUS, TRIVALENT, GEINACTIVEERD",
    "TETANUSTOXOÏDE, GEADSORBEERD, GEINACTIVEERD"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h17641.pdf",
  "authorised_at": "1993/12/02",
  "procedure_number": "NL/H/6067/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "17641",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about diphtherie-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console